+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Emergent BioSolutions, Inc. - logo

Emergent BioSolutions manufactures immunobiotics such as vaccines and immune globulins that assist the body’s immune system. The company’s biodefense segment develops drugs such as BioThrax, a vaccine for the prevention of anthrax, for use against biological agents. Other products in preclinical development include drugs for the treatment of patients exposed to anthrax and botulinum toxin. The company, which was founded in 1998, is based in Rockville, Maryland.

Biodefence Market Report 2023-2033 - Product Thumbnail Image

Biodefence Market Report 2023-2033

  • Report
  • January 2023
  • 197 Pages
  • Global
From
From
Global Biodefense Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global Biodefense Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Human Papillomavirus (HPV) Vaccine Global Market Report 2024 - Product Thumbnail Image

Human Papillomavirus (HPV) Vaccine Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
Respiratory Disease Vaccine Global Market Report 2024 - Product Thumbnail Image

Respiratory Disease Vaccine Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Influenza Vaccines Market Report 2023-2033 - Product Thumbnail Image

Influenza Vaccines Market Report 2023-2033

  • Report
  • October 2023
  • 192 Pages
  • Global
From
From
Global Hepatitis B Therapeutics Market 2022-2026 - Product Thumbnail Image

Global Hepatitis B Therapeutics Market 2022-2026

  • Report
  • April 2022
  • 120 Pages
  • Global
From
Loading Indicator